@ARTICLE{
author={Manojlovic Nebojsa S,Manojlovic Stevan},
year={2026},
title={Letter to the Editor: Rethinking Helicobacter pylori-associated gastroduodenal disease through a systemic immune lens},
journal={WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY},
volume={18},
number={5},
pages={-},
document_type={Letter},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Rancic Nemanja K,Manojlovic Stevan},
year={2026},
title={Systemic IgG/IgA Balance and Antigen-Specific Seroreactivity as Predictors of the Topographic Distribution of Helicobacter pylori-Associated Gastritis},
journal={GASTROINTESTINAL DISORDERS},
volume={8},
number={1},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Savic Goran,Manojlovic Stevan},
year={2024},
title={Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how},
journal={WORLD JOURNAL OF GASTROINTESTINAL SURGERY},
volume={16},
number={5},
pages={-},
document_type={Editorial Material},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Bokonjic Dubravko R},
year={2022},
title={Seroreactivity against Helicobacter pylori VacA, 50 kDa, and 30 kDa along with alarm features may improve the diagnostic approach to uninvestigated dyspepsia - a pilot study},
journal={VOJNOSANITETSKI PREGLED},
volume={79},
number={5},
pages={448-455},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Bokonjic Dubravko R},
year={2022},
title={Simultaneous and alternative IgG seroreactivity against Helicobacter pylori antigens VacA, 30 kDa and 50 kDa is a better biomarker approach for the outcome of infection than VacA and 50 kDa alone},
journal={VOJNOSANITETSKI PREGLED},
volume={79},
number={2},
pages={133-141},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Savic Goran,Nikolic Bojan,Rancic Nemanja K},
year={2022},
title={Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy},
journal={WORLD JOURNAL OF CLINICAL CASES},
volume={10},
number={3},
pages={899-918},
document_type={Article},
} 

@ARTICLE{
author={Stemmer Salomon M,Manojlovic Nebojsa S,...,Natosevic Sladjana,...,(broj koautora 21)},
year={2021},
title={Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial},
journal={CANCERS},
volume={13},
number={2},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Petrovic Stanko S,Vasiljevska Milijana M,Obradovic Slobodan D,Tarabar Dino K,Doder Radoje,Majstorovic Ivana J,Petrovic Marijana,Magic Zvonko M,Cikota-Aleksic Bojana M,Perisic Nenad,Brcerevic Irina A,Manojlovic Nebojsa S,Rancic Nemanja K},
year={2020},
title={Antiplatelet agents'-ticagrelol and eptifibatide-safety in experimental colitis in mice},
journal={TURKISH JOURNAL OF GASTROENTEROLOGY},
volume={31},
number={6},
pages={451-458},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Tufegdzic Ivana Z,Ristanovic Elizabeta S,Bokonjic Dubravko R},
year={2020},
title={Serum IgG antibodies against Helicobacter pylori low molecular weight antigens 50kDa, 30kDa and Urease A 26 kDa, along with vacuolating cytotoxin A are associated with the outcome of the infection},
journal={VOJNOSANITETSKI PREGLED},
volume={77},
number={4},
pages={405-412},
document_type={Article},
} 

@ARTICLE{
author={Stemmer Salomon M,Manojlovic Nebojsa S,...,Natosevic Sladjana,...,(broj koautora 20)},
year={2019},
title={A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A(3) adenosine receptor agonist (A(3)AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carcinoma (HCC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={37},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Van Cutsem Eric,Hidalgo Manuel,Canon Jean-Luc,Macarulla Teresa,Bazin Igor,Poddubskaya Elena,Manojlovic Nebojsa S,Radenkovic Dejan V,Verslype Chris,Eric Raymond,Cubillo Antonio,Schueler Armin,Zhao Charles,Hammel Pascal},
year={2018},
title={Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer},
journal={INTERNATIONAL JOURNAL OF CANCER},
volume={143},
number={8},
pages={2053-2064},
document_type={Article},
} 

@ARTICLE{
author={Kim Tae Won,Elme Anneli,Park Joon Oh,Udrea Anghel Adrian,Kim Sun Young,Ahn Joong Bae,Valencia Ricardo Villalobos,Krishnan Srinivasan,Manojlovic Nebojsa S,Guan Xuesong,Lofton-Day Catherine,Jung A Scott,Vrdoljak Eduard},
year={2018},
title={Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer},
journal={CLINICAL COLORECTAL CANCER},
volume={17},
number={3},
pages={206-214},
document_type={Article},
} 

@ARTICLE{
author={Glimelius Bengt,Manojlovic Nebojsa S,Pfeiffer Per,Mosidze Baadur,Kurteva Galina,Karlberg Mia,Mahalingam Devalingam,Buhl Jensen Peter,Kowalski Jan,Bengtson Marie,Nittve Malin,Nasstrom Jacques},
year={2018},
title={Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx((R))): a placebo-controlled randomised phase II study (PLIANT)},
journal={ACTA ONCOLOGICA},
volume={57},
number={3},
pages={393-402},
document_type={Article},
} 

@ARTICLE{
author={Glimelius Bengt,Manojlovic Nebojsa S,Pfeiffer Per,Mosidze Baadur,Petrova-Kurteva Galina,Karlberg Mia,Mahalingam Devalingam,Bengtson Marie,Nasstrom Jacques},
year={2016},
title={Persistent prevention of CIPN using calmangafodipir (Pled Ox): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Vrdoljak Eduard,...,Kusic Zvonko,...,Manojlovic Nebojsa S,...,(broj koautora 16)},
year={2016},
title={Association of ECOG performance status with efficacy in patients receiving panitumumab with best supportive care (BSC) vs BSC alone for chemorefractory metastatic colorectal cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kim Tae Won,...,Kusic Zvonko,...,Manojlovic Nebojsa S,...,(broj koautora 16)},
year={2016},
title={Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kim Tae Won,...,Manojlovic Nebojsa S,...,(broj koautora 16)},
year={2016},
title={A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer},
journal={BRITISH JOURNAL OF CANCER},
volume={115},
number={10},
pages={1206-1214},
document_type={Article},
} 

@ARTICLE{
author={Van Cutsem Eric,Hidalgo Manuel,Bazin Igor,Canon Jean-Luc,Poddubskaya Elena,Manojlovic Nebojsa S,Milella Michele,Radenkovic Dejan V,Verslype Chris,Guo Wei,Damstrup Lars,Hammel Pascal},
year={2015},
title={Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={33},
number={3},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Palibrk Ivan G,Milicic Biljana R,Stojiljkovic Ljuba,Manojlovic Nebojsa S,Dugalic Vladimir D,Bumbasirevic Vesna D,Kalezic Nevena K,Zuvela Marinko M,Milicevic Miroslav N},
year={2012},
title={Clamp-Crushing vs. Radiofrequency-Assisted Liver Resection: Changes in Liver Function Tests},
journal={HEPATO-GASTROENTEROLOGY},
volume={59},
number={115},
pages={800-804},
document_type={Article},
} 

@ARTICLE{
author={Kovcin Vladimir N,Manojlovic Nebojsa S,Jovanovic Dusan,Vrbic Svetislav,Andric Zoran G,Nikolic Ivan V,Pantelic Aleksandra,Ursulovic Tamara B},
year={2011},
title={The Impact of Capecitabine Dose Modification to Duration of Treatment in Patients with Metastatic Colorectal Cancer - First Results From Axiom Trial},
journal={ANNALS OF ONCOLOGY},
volume={22},
number={},
pages={v101-v102},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kovcin Vladimir N,Jovanovic Dusan,Manojlovic Nebojsa S,Vrbic Svetislav,Andric Zoran G,Nikolic Ivan V,Pantelic Aleksandra,Radosavljevic Davorin Z},
year={2011},
title={Prospective Evaluation of Response and Conversion-to-resectability Rate in Patients with Metastatic Colorectal Cancer After 4 Cycles Capox/folfox Plus Bevacizumab - Updated Results From Relevant Trial},
journal={ANNALS OF ONCOLOGY},
volume={22},
number={},
pages={v101-v101},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Radic S,Markovic M,Kovcin Vladimir N,Andric Zoran G,Manojlovic Nebojsa S,Jovanovic Dusan,Nikolic Ivan V,Pantelic Aleksandra,Popov Ivan P},
year={2010},
title={Relevant: Prospective Evaluation of Efficacy and Safety of Bevacizumab Therapy in Metastatic Colorectal Carcinoma; Interim Analysis of Resecatability Rate},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={217-217},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Babic Dragana,Stojanovic Snezana,Filipovic Ivana,Doder Radoje},
year={2008},
title={Capecitabine cardiotoxicity - Case reports and literature review},
journal={HEPATO-GASTROENTEROLOGY},
volume={55},
number={85},
pages={1249-1256},
document_type={Review},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Babic Dragana,Filipovic-Ljeskovic Ivana M,Pilcevic Dijana R},
year={2008},
title={Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis},
journal={HEPATO-GASTROENTEROLOGY},
volume={55},
number={82-83},
pages={807-813},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Babic Dragana},
year={2004},
title={Radiation-induced rectal ulcer - Prognostic factors and medical treatment},
journal={HEPATO-GASTROENTEROLOGY},
volume={51},
number={56},
pages={447-450},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Nikolic M,Pilcevic Dijana R,Josifovski Jeremija J,Babic Dragana},
year={2004},
title={Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease},
journal={HEPATO-GASTROENTEROLOGY},
volume={51},
number={55},
pages={282-284},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Babic Dragana,Filipovic-Ljeskovic Ivana M,Pilcevic Dijana R},
year={2002},
title={Anti Helicobacter pylori immune response in patients with gastric cancer, gastric lymphoma, gastritis and duodenal ulcer},
journal={GUT},
volume={51},
number={},
pages={A57-A57},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Manojlovic Nebojsa S,Babic Dragana},
year={2002},
title={Age, sex, primary tumor site and degree of tumor differentiation as prognostic factors in patients with Dukes c stage colon cancer receiving adjuvant treatment},
journal={INTERNATIONAL JOURNAL OF CANCER},
volume={},
number={},
pages={229-229},
document_type={Meeting Abstract},
}